| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |